130 related articles for article (PubMed ID: 29187718)
1. [Affinity of Luliconazole for Human Nail Derived Keratin].
Hasuko M; Shiomi R; Takahashi Y; Motoba K; Hirano H; Tsuboi R; Inagaki K
Med Mycol J; 2017; 58(4):J113-J119. PubMed ID: 29187718
[TBL] [Abstract][Full Text] [Related]
2. [Affinity of Luliconazole to Keratin Prepared from Healthy Human Nailand Porcine Hoof].
Hasuko M; Toga T; Tsunemitsu T; Matsumoto T; Koga H; Hirano H; Tsuboi R
Med Mycol J; 2016; 57(1):J7-12. PubMed ID: 26936352
[TBL] [Abstract][Full Text] [Related]
3. A comparative study between two antifungal agents, Luliconazole and Efinaconazole, of their preventive effects in a Trichophyton-infected guinea pig onychomycosis model.
Nakamura A; Hirakawa S; Nagai H; Inagaki K
Med Mycol; 2021 Mar; 59(3):289-295. PubMed ID: 33539539
[TBL] [Abstract][Full Text] [Related]
4. The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.
Sugiura K; Sugimoto N; Hosaka S; Katafuchi-Nagashima M; Arakawa Y; Tatsumi Y; Jo Siu W; Pillai R
Antimicrob Agents Chemother; 2014 Jul; 58(7):3837-42. PubMed ID: 24752277
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
Kawai M
Med Mycol J; 2019; 60(3):71-74. PubMed ID: 31474693
[TBL] [Abstract][Full Text] [Related]
6. Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.
Matsuda Y; Sugiura K; Hashimoto T; Ueda A; Konno Y; Tatsumi Y
PLoS One; 2016; 11(7):e0159661. PubMed ID: 27441843
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of Characteristics of Two Topical Therapeutic Agents for Onychomycosis].
Shimamura T; Miyamae A; Imai A; Hirayanagi K; Iwanaga T; Kubota N; Shibuya K
Med Mycol J; 2016; 57(4):J141-J147. PubMed ID: 27904059
[TBL] [Abstract][Full Text] [Related]
8. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
Monti D; Mazzantini D; Tampucci S; Vecchione A; Celandroni F; Burgalassi S; Ghelardi E
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332076
[TBL] [Abstract][Full Text] [Related]
9. A novel method for predicting the efficacy of topical drugs on onychomycosis: A comparison of efinaconazole and luliconazole.
Masumoto A; Takagi M; Sugiura K; Matsuda Y; Nakamura S; Tatsumi Y
J Mycol Med; 2022 Aug; 32(3):101259. PubMed ID: 35255449
[TBL] [Abstract][Full Text] [Related]
10. Preparation and
Lee BC; Pangeni R; Na J; Koo KT; Park JW
Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
[TBL] [Abstract][Full Text] [Related]
11. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of Luliconazole in Nail Plate by In Vitro Permeation and Efficacy by Zone of Inhibition Test after Treatment of Luliconazole Nail Solution].
Shimamura T; Miyamae A; Arai M; Minemura A; Nozawa A; Kubota N
Med Mycol J; 2016; 57(1):J19-25. PubMed ID: 26936348
[TBL] [Abstract][Full Text] [Related]
13. How effective is efinaconazole in the management of onychomycosis?
Gupta AK; Cernea M
Expert Opin Pharmacother; 2016; 17(4):611-8. PubMed ID: 26809447
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal Activity of Luliconazole Nail Solution on in vitro and in vivo Onychomycosis Model].
Shimamura T; Hasegawa N; Kubota N
Med Mycol J; 2016; 57(1):J13-8. PubMed ID: 26936347
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Topical Antifungals Using a New Predictive Animal Model for Efficacy against Severe Tinea Unguium: A Comparison of Efinaconazole and Luliconazole.
Masumoto A; Sugiura K; Matsuda Y; Tachibana H; Tatsumi Y
Mycopathologia; 2022 Dec; 187(5-6):481-489. PubMed ID: 36094777
[TBL] [Abstract][Full Text] [Related]
17. Infected nail plate model made of human hair keratin for evaluating the efficacy of different topical antifungal formulations against Trichophyton rubrum in vitro.
Lusiana ; Reichl S; Müller-Goymann CC
Eur J Pharm Biopharm; 2013 Aug; 84(3):599-605. PubMed ID: 23419812
[TBL] [Abstract][Full Text] [Related]
18. Topical application of acidified nitrite to the nail renders it antifungal and causes nitrosation of cysteine groups in the nail plate.
Finnen MJ; Hennessy A; McLean S; Bisset Y; Mitchell R; Megson IL; Weller R
Br J Dermatol; 2007 Sep; 157(3):494-500. PubMed ID: 17627796
[TBL] [Abstract][Full Text] [Related]
19. Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
Hossin B; Rizi K; Murdan S
Eur J Pharm Biopharm; 2016 May; 102():32-40. PubMed ID: 26924329
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
